As part of Volunteer Week, we would like to shine a spotlight on Mark Inston. Q1. How did you become connected to Snowdome? A. I am a patient of one of the founders, Miles Prince.
This week is Volunteer week. The Snowdome Foundation would not exist without the support of so many generous individuals and organisations that give up their time and valuable resources to help us achieve our mission.
John Tandy was an exceptionally busy GP working from early in the morning til late at night until he was diagnosed with myeloma 10 years ago. He noticed a pain in his foot for 6
Another incredible story of CAR T-cell therapy saving an Australian blood cancer patient’s life. However, the young mum had to travel to the USA for treatment. To hear her story click here. Snowdome is raising
We are delighted to present the Snowdome Foundation 2018 Annual Review. The review highlights some of our amazing achievements over the past year as well as paying tribute to our many supporters, donors and pro bono partners who helped
The Federal Government announced that it will fund Chimeric Antigen Receptor T cell (CAR T-cell) therapy with Kymriah for the treatment of acute lymphoblastic leukaemia (ALL) in paediatric and young adult patients who have relapsed
As of 1st May 2019 Inotuzumab (Besponsa) will be available on the PBS for patients with relapsed acute lymphocytic leukaemia (ALL) or refractory CD22 positive B-cell precursor ALL. The treatment costs $120,000 per course but
“You have the opportunity to help one patient in front of you when you are a clinician, but when working in the laboratory you have the opportunity to help millions of patients when you make
Tom Long so generously told of his battle with myeloma to Lisa Wilkinson on The Project to raise awareness for Snowdome. Tom wanted to ensure that funds were raised for blood cancer research to help
In December 2018 the Australian Therapeutic Goods Administrator (TGA) approved the use of chimeric antigen receptor T cell (CAR-T cell) therapy for two types of blood cancer, diffuse large B cell lymphoma (DLBCL) and B
